Table 2.
Group | Treatment Group | Control Group | ||||||
---|---|---|---|---|---|---|---|---|
Parameter | T0 | T30 | T60 | T90 | T0 | T30 | T60 | T90 |
Sperm-Rich Fraction Volume (mL) | 0.99 ± 0.04 | 1.23 ± 0.39 | 1.03 ± 0.10 | 1.07 ± 0.19 | 0.95 ± 0.08 | 1.24 ± 0.45 | 1.43 ± 0.73 | 1.14 ± 0.35 |
Concentration (spz × 106/mL) | 390.86 a ± 82.13 | 464.57 a,b ± 153.12 | 873.57 b,# ± 262.04 | 899.43 b,# ± 150.67 | 377.56 ± 72.48 | 420.38 ± 67.8 | 376.79 § ± 62.22 | 387.89 § ± 89.77 |
Total Sperm Count (spz × 106) | 386.57 a ± 88.22 | 613.71 a,b ± 392.29 | 892.13 b,# ± 247.01 | 956.00 b,# ± 175.85 | 358.83 ± 72.70 | 533.30 ± 177.53 | 567.36 § ± 363.18 | 440.6 § ± 150.8 |
Total Motility (%) | 93.00 ± 7.44 | 96.43 ± 6.40 | 98.86 ± 1.07 | 98.71 ± 0.76 | 94.43 ± 6.97 | 95.57 ± 6.16 | 95.86 ± 5.28 | 96.29 ± 5.36 |
Progressive Motility (%) | 51.29 a ± 22.51 | 71.86 a,b ± 9.92 | 77.86 b,# ± 11.51 | 82.86 b,# ± 7.99 | 55.43 ± 14.02 | 65.57 ± 15.49 | 62.14 § ± 12.05 | 68.43 § ± 13.59 |
Rapid (%) | 73.29 a ± 10.24 | 83.40 a,b,# ± 6.20 | 86.43 b,# ± 3.64 | 86.79 b,# ± 3.58 | 71.43 ± 11.32 | 73.86 § ± 4.79 | 79.71 § ± 6.43 | 80.43 § ± 5.21 |
Medium (%) | 6.14 a ± 3.34 | 8.86 a,b ± 6.54 | 10.86 a,b,# ± 3.08 | 11.00 b ± 2.31 | 6.43 ± 7.13 | 5.29 ± 3.99 | 5.29 § ± 6.47 | 8.14 ± 3.56 |
Slow (%) | 11.14 a ± 5.76 | 5.29 a,b,# ± 2.75 | 2.14 b,# ± 1.68 | 1.79 b,# ± 1.73 | 12 A ± 4.69 | 9.86 A,§ ± 3.14 | 6.14 B,§ ± 2.95 | 4.71 B,§ ± 2.05 |
Static (%) | 9.43 a ± 3.51 | 2.43 b,# ± 1.62 | 0.86 b,# ± 0.38 | 0.71 b,# ± 0.49 | 10.14 A ± 2.1 | 11 A,§ ± 2.56 | 8.86 A,B,§ ± 3.64 | 6.71 B,§ ± 3.41 |
HOS (% curled) | 91.14 a ± 4.22 | 94.71 a,b,# ± 4.61 | 97.43 b,# ± 1.62 | 96.29 b,# ± 2.36 | 91.14 ± 2.95 | 90.57 § ± 4.27 | 92.14 § ± 5.51 | 92.71 § ± 2.25 |
Sperm Viability (Eo-Nig) (%) | 91.29 a ± 5.94 | 94.86 a,b,# ± 3.85 | 98.71 b,# ± 1.25 | 98.71 b,# ± 0.95 | 91.13 ± 0.69 | 91.57 § ± 3.64 | 91.86 § ± 3.34 | 93.65 § ± 3.80 |